Revenue Growth of 17% Led by Significant OEM GrowthDebt Restructuring and Concurrent Capital Raise Enhance Financial Position and LiquidityInitiates Corporate Optimization ProgramGuides ...

Q4 2024 revenue of $1.5 million in pharma services; full year revenue of $1.9 millionGraftAssure RUO assay launched July ...

Canadian Solar Inc. ('Canadian Solar' or the 'Company') (NASDAQ: CSIQ) today announced financial results for the fourth quarter and full year ended December 31, 2024.